What you need to know about Rexulti (Brexpiprazole)

Video: Using the REXULTI Savings Card

Table 1 from Brexpiprazole (Rexulti): A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive Disorder.

FAQ for agitation that may happen with dementia due to Alzheimer's disease

dtw Research, Inc on X: Throughout 2019, Rexulti produces the largest volume of marketing materials🔍📈 #lundbeck #otsuka #rexulti #brexpiprazole #depression #majordepressivedisorder #MDD #centralnervoussystem #CNS #antidepressants #yearendreview

Brexpiprazole Warnings: Side Effects of Rexulti

Brexpiprazole for schizophrenia and as adjunct for major depressive disorder

Brexpiprazole Rexulti - MedWorks Media

Helpful Tools REXULTI® (brexpiprazole)

Brexpiprazole - Mechanism of Action and Clinical Application

Brexpiprazole Updated - Gateway Psychiatric

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

Michael Okun on X: Brexpiprazole (Rexulti) approved by FDA for #Alzheimers agitation. Will it find its way to #Parkinsons? Depends on if it makes motor symptoms significantly worse. It works on D2

REXULTI® (brexpiprazole), Agitation associated with dementia due to Alzheimer's disease

New Drug Product: REXULTI - MPR

Brexpiprazole: Package Insert